Correlation Between Viridian Therapeutics and Elicio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Elicio Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Elicio Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Elicio Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viridian and Elicio is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Elicio Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Elicio Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 17.77 times less return on investment than Elicio Therapeutics. But when comparing it to its historical volatility, Viridian Therapeutics is 1.9 times less risky than Elicio Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 920.00 in Elicio Therapeutics on August 23, 2024 and sell it today you would lose (408.00) from holding Elicio Therapeutics or give up 44.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Elicio Therapeutics
Performance |
| Timeline |
| Viridian Therapeutics |
| Elicio Therapeutics |
Viridian Therapeutics and Elicio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Elicio Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Elicio Therapeutics vs. ZyVersa Therapeutics | Elicio Therapeutics vs. Sonnet Biotherapeutics Holdings | Elicio Therapeutics vs. Zura Bio Limited | Elicio Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |